Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
At-home subcutaneous furosemide for fluid overload in heart failure with chronic kidney disease
ISRCTN17152353Phase 2Recruiting
- Sponsor
- St George's University Hospitals NHS Foundation Trust
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of furosemide in heart failure (HF) and chronic kidney disease (CKD), sponsored by St George's University Hospitals NHS Foundation Trust. Primary endpoints: Number of participants consented to be randomised at end of stage 1, Number of participants able to complete the intervention and 1 more. Started Nov 2025; status: recruiting.
02
Drugs
furosemide
03
Conditions
heart failure (HF)chronic kidney disease (CKD)
Beyond the preview
Go deeper on ISRCTN17152353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN17152353.